Aditxt Market Capitalization from 2010 to 2024

ADTX Stock  USD 1.23  0.02  1.65%   
Aditxt Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 76.2 M in 2024.
Check Aditxt financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aditxt's main balance sheet or income statement drivers, such as Interest Expense of 6.7 M, Selling General Administrative of 11.9 M or Tax Provision of 0.0, as well as many indicators such as Price To Sales Ratio of 118, Dividend Yield of 0.0 or PTB Ratio of 5.24. Aditxt financial statements analysis is a perfect complement when working with Aditxt Valuation or Volatility modules.
  
Check out the analysis of Aditxt Correlation against competitors.

Latest Aditxt's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Aditxt Inc over the last few years. It is Aditxt's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aditxt's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 165.7 K10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Aditxt Market Capitalization Regression Statistics

Arithmetic Mean834,994,630
Geometric Mean602,176,586
Coefficient Of Variation51.07
Mean Deviation358,477,599
Median1,079,411,174
Standard Deviation426,391,225
Sample Variance181809.5T
Range1B
R-Value(0.77)
Mean Square Error78453.9T
R-Squared0.60
Significance0.0007
Slope(73,810,375)
Total Sum of Squares2545332.7T

Aditxt Market Capitalization History

202476.2 M
202380.2 M
202285.7 M
2021409.4 M

About Aditxt Financial Statements

Aditxt investors use historical fundamental indicators, such as Aditxt's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Aditxt. Please read more on our technical analysis and fundamental analysis pages.
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Aditxt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 58 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Aditxt Stock Analysis

When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.